Is HLA-A*3101 screening cost-effective for preventing carbamazepine-induced severe toxidermia?

Details

Ressource 1Download: BIB_62DC0CDAF100.P001.pdf (4896.59 [Ko])
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_62DC0CDAF100
Type
Inproceedings: an article in a conference proceedings.
Publication sub-type
Poster: Summary – with images – on one page of the results of a researche project. The summaries of the poster must be entered in "Abstract" and not "Poster".
Collection
Publications
Institution
Title
Is HLA-A*3101 screening cost-effective for preventing carbamazepine-induced severe toxidermia?
Title of the conference
European and Swiss Congress of Internal Medicine
Author(s)
Decollogny Anne, Pinget Christophe, Rossetti Andrea, Buclin Thierry, Livio Françoise
Address
Geneva, Switzerland, May 14-16, 2014
Publication state
Published
Issued date
2014
Language
english
Create date
02/06/2014 10:07
Last modification date
27/08/2019 10:06
Usage data